1010
P. Shanmugavelan, M. Sathishkumar, S. Nagarajan, R. Ranganathan, and A. Ponnuswamy
Vol 51
[2] Tanabe, Y.; Suzukamo, G.; Komuro, Y.; Imanishi, N.; Morooka,
S.; Enomoto, M.; Kojima, A.; Sanemitsu, Y.; Mizutani, M. Tetrahedron Lett
1991, 32, 379.
[3] Liu H.-L.; Li Z.; Anthonsen T.. Molecules 2000, 5, 1055.
[4] Kato, T.; Ozaki, T.; Ohi, N. Tetrahedron Asymmetry 1999,
10, 3963.
[5] Previtera, T.; Vigorita, M. G.; Bisila, M.; Orsini, F.; Benetolla,
F.; Bombieri, G. Eur J Med Chem 1994, 29, 317.
[6] Balzarini, J.; Orzeszko, B.; Maurin, J. K.; Orzeszko, A. Eur J
Med Chem 2007, 42, 993.
[7] Knutsen, L. J. S.; Hobbs, C. J.; Earnshaw, C. G. Bioorg Med
Chem Lett 2007, 17, 662.
[8] Mujeebur Rahman, V. P.; Mukhtar, S.; Ansari, W. H. Eur J
Med Chem 2005, 40, 173.
[9] Look, G. C.; Schullek, J. R.; Homes, C. P.; Chinn, J. P.; Gordon,
E. M.; Gallop, M. A. Bioorg Med Chem Lett 1996, 6, 707.
[10] Barreca, M. L.; Chimirri, A.; Luca, L. D.; Monforte, A.; Monforte,
P.; Rao, A.; Zappala, M.; Balzarini, J.; De Clercq, E.; Pannecouque, C.;
Witvrouw, M. Bioorg Med Chem Lett 2001, 1793.
[11] (a) Brown, C. F. Chem Rev 1961, 61, 463; (b) Singh,
S. P.; Parmar, S. S.; Raman, K.; Stenberg, V. I. Chem Rev 1981,
81, 175.
[12] (a) Gududuru, V.; Nguyen, V.; Dalton, J. T.; Miller, D. D.
Synlett 2004, 13, 2357; (b) Cesur, Z.; Guner, H.; Otuk, G. Eur J Med
Chem 1994, 29, 981; (c) Vicini, P.; Geronikaki, A.; Anastasia, K.;
Incertia, M.; Zania, F. Bioorg Med Chem 2006, 14, 3859; (d) Ottana,
R.; Maccari, R.; Barreca, M. L.; Bruno, G.; Rotondo, A.; Rossi, A.;
Chiricosta, G.; Di Paola, R.; Sautebin, L.; Cuzzocread, S.; Vigorita, M.
G. Bioorg Med Chem 2005, 13, 4243; (e) Holmes, C. P.; Chinn, J. P.;
Look, G. C.; Gordon, E. M.;Gallop, M. A. J Org Chem 1995, 60, 7328;
(f) Anderluh, M.; Jukic, M.; Petric, R.Tetrahedron 2009, 65, 344; (g)
Cunico, W.; Gomes, C. R. B.; Ferreira, L. G.; Capri, L. R.; Soares, M.;
Wardell, S. M. S. V. Tetrahedron Lett 2007, 48, 6217; (h) de Vries, A.
H. M.; Hof, R. P.; Staal, D.; Kellogg, R. M.; Feringa, B. L. Tetrahedron
Asymmetry 1997, 8, 1539.
[13] Srivastava, S. K.; Srivastava, S. L.; Srivastava, S. D. J Indian
Chem Soc 2000, 77, 104.
[14] Sharma, R. C.; Kumar, D. J Indian Chem Soc 2000,
77, 492.
[15] Srivastava, T.; Haq, W.; Katti, S. B. Tetrahedron 2002,
58, 7619.
[16] Rawal, R. K.; Srivastava, T.; Haq, W.; Katti, S. B. J Chem Res
2004, 5, 368.
(d, 1H, J = 15.6Hz, SCH2), 3.74 (d, 1H, J = 15.6Hz, SCH2), 3.61
(d, 1H, J = 15.0Hz, NCH2); 13C NMR (75 MHz, CDCl3): d
170.76, 140.30, 128.71, 128.26, 127.84, 127.66, 125.79, 124.00,
57.97, 46.19, 32.85; Anal. Calcd for C14H13NOS2: C, 61.06; H,
4.76; N, 5.09; S, 23.29. Found: C, 61.07; H, 4.75; N, 5.08; S, 23.28.
3-Benzyl-2-(pyridine-2-yl)thiazolidin-4-one (4h).
Gummy
matter. Yield: 95%. 1H NMR (300 MHz, CDCl3): d 7.09 (m, 2H,
ArH), 7.21–7.38 (m, 7H, ArH), 5.38 (s, 1H, NCHS), 5.16 (d, 1H,
J = 14.7Hz, NCH2), 3.90 (d, 1H, J = 15.3 Hz, SCH2), 3.76 (d, 1H,
J = 15.6Hz, SCH2), 3.52 (d, 1H, J = 14.7Hz, NCH2); 13C NMR
(75 MHz, CDCl3): d 171.18, 139.10, 135.24, 131.04, 129.15,
129.07, 128.71, 128.36, 127.87, 127.10, 62.69, 47.16, 32.96;
Anal. Calcd for C15H14N2OS: C, 66.64; H, 5.22; N, 10.36; S,
11.86. Found: C, 66.63; H, 5.21; N, 10.35; S, 11.85.
Ethyl 2-(4-oxo-2-phenylthiazolidin-3-yl)acetate (4i).
Gummy matter. Yield: 94%. 1H NMR (300 MHz, CDCl3): d
7.32–7.40 (m, 5H, ArH), 5.84 (s, 1H, NCHS), 4.43 (d, 1H,
J = 17.7 Hz, NCH2), 4.15 (m, 2H, OCH2CH3), 3.80 (s, 2H,
SCH2), 3.30 (d, 1H, J = 17.4 Hz, NCH2), 1.23 (t, 3H, J = 6.9 Hz
OCH3CH2); 13C NMR (75 MHz, CDCl3): d 171.93, 167.87,
137.77, 129.51, 129.08, 127.60, 63.65, 61.45, 43.81, 32.69,
29.61, 14.00; Anal. Calcd for C13H15NO3S: C, 58.85; H, 5.70;
N, 5.28; S, 12.09. Found: C, 58.83; H, 5.71; N, 5.28; S, 12.08.
Ethyl 2-(2-(4-methoxyphenyl)4-oxothiazolidin-3-yl)acetate
(4j).
Gummy matter. Yield: 96%. 1H NMR (300 MHz,
CDCl3): d 7.28 (d, 2H, J = 9.6 Hz, ArH), 6.89 (d, 2H, J = 9.6 Hz,
ArH), 5.81 (s, 1H, NCHS), 4.39 (d, 1H, J = 17.7 Hz, NCH2),
4.14 (m, 2H, OCH2CH3), 3.79 (s, 3H, OCH3), 3.78 (s, 2H,
SCH2), 3.29 (d, 1H, J = 17.7 Hz, NCH2), 1.24 (t, 3H, J = 7.2 Hz,
OCH2CH3); 13C NMR (75 MHz, CDCl3): d 171.80, 167.97,
160.50, 129.19, 114.42, 63.41, 61.43, 55.32, 43.69, 32.83,
29.63, 14.03; Anal. Calcd for C14H17NO4S: C, 56.93; H, 5.80;
N, 4.74; S, 10.86. Found: C, 56.93; H, 5.81; N, 4.75; S, 10.85.
Methyl 2-(2-(2-chlorophenyl)-4-oxothiazolidin-3-yl)acetate
(4m).
Gummy matter. Yield 93%. 1H NMR (300 MHz,
CDCl3): d 7.28–7.45 (m, 4H, ArH), 6.28 (s, 1H, NCHS), 4.54
(d, 1H, J = 17.7 Hz, NCH2), 3.79 (s, 2H, SCH2), 3.72 (s, 3H,
OCH3), 3.39 (d, 1H, J = 17.7 Hz, NCH2); 13C NMR (75 MHz,
CDCl3): d 172.44, 168.09, 135.66, 132.04, 131.18, 130.19,
127.72, 126.55, 59.92, 52.45, 44.01, 32.03; Anal. Calcd for
C12H12ClNO3S: C, 50.44; H, 4.23; N, 4.90; S, 11.22. Found: C,
50.46; H, 4.23; N, 4.90; S, 11.21.
Methyl 2-(2-(furan-2-yl)4-oxothiazolidin-3-yl)acetate (4n).
Gummy matter. Yield: 94%. 1H NMR (300 MHz, CDCl3): d 7.45
(s, 1H, ArH), 6.44 (s, 1H, ArH), 6.36 (s, 1H, ArH), 5.88 (s, 1H,
NCHS), 4.45 (d, 1H, J = 17.7 Hz, NCH2), 3.81 (d, 1H,
J = 15.6 Hz, SCH2), 3.70 (s, 3H, OCH3), 3.65 (d, 1H, merged
with OCH3, SCH2), 3.47 (d, 1H, J = 17.7 Hz, NCH2); 13C NMR
(75 MHz, CDCl3): d 170.54, 167.89, 149.55, 143.54, 110.18,
109.73, 55.70, 51.85, 43.26, 31.51; Anal. Calcd for
C10H11NO4S: C, 49.78; H, 4.60; N, 5.81; S, 13.29. Found: C,
49.77; H, 4.60; N, 5.80; S, 13.30.
[17] Chen, H.; Bai, J.; Zhao, L.; Yuan, X. G.; Li, X. L.; Cao, K. Q.
Chin J Org Chem 2008, 28, 1092.
[18] (a) Zhou, Z. Z.; Huang, W.; Ji, F. Q.; Ding, M. W.; Yang, G. F.
Heteroat Chem. 2007, 18, 381; (b) Dandia, A.; Singh, R.; Khaturia,
S.; Mérienne, C.; Morgant, G.; Loupy, A. Bioorg Med Chem 2006,
14, 2409; (c) Fraga-Dubreuil, J.; Bazureau, J. P. Tetrahedron 2003,
59, 6121.
[19] (a) Wamhoff, H.; Richardt, G.; Stölben, S. Adv Heterocycl
Chem 1995, 64, 159; (b) Fresneda, P. M.; Molina, P.; Synlett 2004, 15,
1; (c) Eguchi, S.. Arkivoc 2005, 2, 98; (d) Brase, S.; Gil, C.; Knepp, K.;
Zimmermann, V. Angew Chem Int Ed 2005, 44, 5188; (e) Eguchi, S..
Heterocycl Chem 2006, 6, 113; (f) Palacios, F.; Alonso, C.; Aparicio,
D.; Rubiales, G.; De los Santos, J. M. Tetrahedron 2007, 63, 523; (g)
Fuwa, H.; Okamura, Y.; Morohashi, Y.; Tomita, T.; Iwatsubo, T.; Kan,
T.; Fukuyama, T.; Natsugari, H. Tetrahedron Lett 2004, 45, 2323; (h)
Marsden, S. P.; McGonagle, A. E.; McKeever-Abbas, B. Org Lett 2008,
10, 2589.
[20] Chen, H.; Zhang, H.; Feng, J.; Li, X.; Jiao, L.; Qin, Z.; Yin, Q.;
Zhang, J. Eur J Org Chem 2009, 6100.
Acknowledgments. The authors thank IRHPA, DST for providing
300 MHz NMR instrument for recording the NMR spectra for the
compounds synthesized and UGC for giving financial support.
[21] Shen, F.; Li, X.; Zhang, X.; Yin, Q.; Qin, Z.; Chen, H.; Zhaipu
Mac, J. Z. Org Biomol Chem DOI: 10.1039/c1ob05675a.
[22] (a) Sathishkumar, M.; Shanmuga velan, P.; Nagarajan S.;
Maheswari, M.; Dinesh, M.; Ponnuswamy, A. Tetrahedron Lett 2011,
52, 2830; (b) Sathishkumar, M.; Nagarajan, S.; Shanmuga velan, P.;
Dinesh, M.; Ponnuswamy, A. J Braz Chem Soc 2011, 22, 2065.
[23] Nagarajan, S.; Shanmugavelan, P.; Sathishkumar, M.;
Priyadharshini, N.; Sudakar, P.; Ponnuswamy, A. Synth Commun
DOI:10.1080/00397911.2011.606043.
REFERENCES AND NOTES
[1] Verma, A.; Saraf, S. K. Eur J Med Chem 2008, 43, 897.
Journal of Heterocyclic Chemistry
DOI 10.1002/jhet